COVER - Continuing Observation After Vicriviroc (VCV) Exposure Registry.

Trial Profile

COVER - Continuing Observation After Vicriviroc (VCV) Exposure Registry.

Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs Vicriviroc (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Adverse reactions
  • Acronyms COVER
  • Sponsors Merck & Co; Schering-Plough
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 02 Dec 2010 Status changed from recruiting to completed as reported by
    • 05 Oct 2008 Planned end date changed from 1 Sep 2012 to 1 Sep 2015 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top